Table of Contents PART 01: Executive summary PART 02: Scope of the report PART 03: Research Methodology PART 04: Introduction • Key market highlights PART 05: Botulinum toxin: An overview PART 06: Pipeline landscape PART 07: Market landscape • Five forces analysis PART 08: Market segmentation by drug categories • Aesthetic drugs market • Therapeutic drugs market PART 09: Geographical segmentation • Botulinum toxin market in Americas • Botulinum toxin market in EMEA • Botulinum toxin market in APAC PART 10: Decision framework PART 11: Drivers and challenges • Market drivers • Impact of drivers on key customer segments • Market challenges • Impact of challenges on key customer segments PART 12: Market trends • Growing importance of medical aesthetics • Technological advancement • Growing demand for anti-aging treatment PART 13: Vendor landscape • Competitive landscape • Key news PART 14: Key vendor analysis • ALLERGAN • Galderma • Ipsen • Merz Pharma • Pfizer • Other prominent vendors PART 15: Appendix • List of abbreviations List of Exhibits Exhibit 01: Pipeline landscape Exhibit 02: Global botulinum toxin market: Snapshot Exhibit 03: Global botulinum toxin market 2016-2021 ($ millions) Exhibit 04: Global botulinum toxin market: Opportunity analysis Exhibit 05: Five forces analysis Exhibit 06: Market segmentation by drug category 2016 Exhibit 07: Global aesthetic drugs market 2016-2021 ($ millions) Exhibit 08: Global therapeutic drugs market 2016-2021 ($ millions) Exhibit 09: Segmentation of global botulinum toxin market based on geography 2016 and 2021 Exhibit 10: Global botulinum toxin market revenue by geography 2016-2021 ($ millions) Exhibit 11: Market scenario in Americas Exhibit 12: Botulinum toxin market in Americas 2016-2021 ($ millions) Exhibit 13: Market scenario in EMEA Exhibit 14: Botulinum toxin market in EMEA 2016-2021 ($ millions) Exhibit 15: Market scenario in APAC Exhibit 16: Botulinum toxin market in APAC 2016-2021 ($ millions) Exhibit 17: Key R&D-based growth drivers Exhibit 18: Impact of drivers Exhibit 19: Impact of challenges Exhibit 20: Top five non-surgical procedures (injectable) of 2015 Exhibit 21: Competitive structure analysis of global botulinum toxin market 2016 Exhibit 22: Competitive analysis of global botulinum toxin market 2016 Exhibit 23: Global market penetration of players in botulinum toxin market 2016 Exhibit 24: ALLERGAN: Key highlights Exhibit 25: ALLERGAN: Strength assessment Exhibit 26: ALLERGAN: Strategy assessment Exhibit 27: ALLERGAN: Opportunity assessment Exhibit 28: Galderma: Key highlights Exhibit 29: Galderma: Strength assessment Exhibit 30: Galderma: Strategy assessment Exhibit 31: Galderma: Opportunity assessment Exhibit 32: Ipsen: Key highlights Exhibit 33: Ipsen: Strength assessment Exhibit 34: Ipsen: Strategy assessment Exhibit 35: Ipsen: Opportunity assessment Exhibit 36: Merz Pharma: Key highlights Exhibit 37: Merz Pharma: Strength assessment Exhibit 38: Merz Pharma: Strategy assessment Exhibit 39: Merz Pharma: Opportunity assessment Exhibit 40: Pfizer: Strength assessment Exhibit 41: Pfizer: Strategy assessment Exhibit 42: Pfizer: Opportunity assessment

ALLERGAN, Galderma, Ipsen, Merz Pharma, Pfizer, Acorda Therapeutics, Aldeyra Therapeutics, Azidus Brasil, Biolab Sanus Farmaceutica, Canbex Therapeutics, DAEWOONG, Emcure Pharmaceuticals, Endo Pharmaceuticals International, Evolus, Fresenius Kabi, GlaxoSmithKline, INSYS THERAPEUTICS, Johnson & Johnson, Lannett, Lanzhou Institute of Biological Products, LEO Pharma, Mylan, Par Pharmaceuticals, PhytoTech Therapeutics, Revance Therapeutics, Sun Pharmaceuticals, Takeda Pharmaceutical, and UroGen Pharma.